Biotron pioneer dies

By Ruth Beran
Tuesday, 16 August, 2005

Peter Gage, an internationally recognised pioneer of the use of ion channels as a treatment for viral diseases, died on August 13 after a long illness.

A professor of physiology at Australian National University's John Curtin School of Medical Research, Gage's research formed the basis of Canberra biotech company Biotron's (ASX:BIT) Virion project, an antiviral treatment nearing commercialisation for the treatment of a range of viruses including HIV and hepatitis C.

Related News

Immune cell boost could enable lasting vaccine protection

A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...

Genes influence when babies start walking

Genetics accounts for about a quarter of the differences in when children take their first steps,...

Novel glycopeptide antibiotic candidate shows promise

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd